Quarterly report pursuant to Section 13 or 15(d)

Goodwill and intangible assets

v2.4.0.6
Goodwill and intangible assets
6 Months Ended
Jan. 31, 2012
Goodwill and Intangible Assets Disclosure [Text Block]

Note 8 – Goodwill and intangible assets


The Company’s change in the net carrying amount of goodwill by business segment is as follows:


 

 

 

 

 

 

 

 

 

 

 

 

 

Enzo Life
Sciences

 

Enzo
Clinical
Labs

 

Total

 

 

 

 

 

 

 

 

 

Balance July 31, 2011

 

$

19,921

 

$

7,452

 

$

27,373

 

Foreign currency translation

 

 

(793

)

 

 

 

(793

)

 

 

   

 

   

 

   

 

Balance January 31, 2012

 

$

19,128

 

$

7,452

 

$

26,580

 

 

 

   

 

   

 

   

 


Intangible assets, all of which are included in the Life Sciences segment, consist of the following:


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 31, 2012

 

July 31, 2011

 

 

 

 

 

 

 

 

 

Gross

 

Accumulated
Amortization

 

Net

 

Gross

 

Accumulated
Amortization

 

Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Finite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Patents

 

$

11,027

 

$

(10,340

)

$

687

 

$

11,027

 

$

(10,278

)

$

749

 

Customer relationships

 

 

12,471

 

 

(3,910

)

 

8,561

 

 

12,789

 

 

(3,472

)

 

9,317

 

Website and acquired content

 

 

1,031

 

 

(809

)

 

222

 

 

1,063

 

 

(748

)

 

315

 

Licensed technology and other

 

 

485

 

 

(250

)

 

235

 

 

649

 

 

(355

)

 

294

 

Indefinitely-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks

 

 

8,931

 

 

 

 

8,931

 

 

9,310

 

 

 

 

9,310

 

 

 

   

 

   

 

   

 

   

 

   

 

   

 

Total

 

$

33,945

 

$

(15,309

)

$

18,636

 

$

34,838

 

$

(14,853

)

$

19,985

 

 

 

   

 

   

 

   

 

   

 

   

 

   

 


At January 31, 2012, the weighted average useful life of finite-lived intangible assets was approximately eight years.


For financial reporting purposes, useful lives for intangibles acquired through acquisitions in the Life Sciences segment have been assigned as follows:


 

 

Customer relationships

5-15 years

Trademarks

Indefinite

Other intangibles

4-5 years